conjugated cannabinoid therapeutic for dermatology / Enveric Biosci - LARVOL DELTA

Enveric Biosciences Signs Definitive Agreement to Acquire Exclusive License for Novel Molecules from Diverse Biotech (PRNewswire) - “Enveric Biosciences…announced today that it has acquired an exclusive, perpetual license from Diverse Biotech…Enveric plans to research and develop these new drugs with the goal of alleviating the side effects that cancer patients experience. Through the conjugation of cannabidiol (CBD) with existing, standard-of-care drugs via Diverse Biotech's patented, advanced chemistry drug delivery platform, Enveric intends to expand its pipeline of development candidates that seek to deliver superior therapeutic outcomes for patients.”

Licensing / partnership • Oncology